Impact of cigarette smoking in type 2 diabetes development

Acta Pharmacologica Sinica

Volumn 30, Issue 6, 2009, Pages 784-787

  Xie, Xi Tao ^a   Liu, Qiang ^b   Wu, Jie ^b   Wakui, Makoto ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c HIROSAKI NATIONAL HOSPITAL   (Japan)

Author keywords

Diabetes; Nicotinic receptor; Smoking

Indexed keywords

INSULIN; NICOTINE; NICOTINIC RECEPTOR; TOLBUTAMIDE;

APOPTOSIS; CIGARETTE SMOKING; HORMONE ACTION; HUMAN; INSULIN RELEASE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; RISK ASSESSMENT; SHORT SURVEY;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; MICROCIRCULATION; NICOTINE; NICOTINIC AGONISTS; RISK FACTORS; SMOKING;

EID: 67549102268     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.49     Document Type: Short Survey

References (33)

1. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-82.
2. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290: 891-7.
3. Cooke JP. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci 2007; 80: 2347-51.
4. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Tromb Vasc Biol 2005; 25: 29-38.
5. Terry ML, Berkowitz HD, Kerstein MD. Tobacco. Its impact on vascular disease. Surg Clin North Am1998; 78: 409-29.
6. Bloomgarden ZT. Obesity and diabetes. Diabetes Care 2000; 23: 1584-90.
7. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci 1998; 851: 311-35.
8. Greenway SC. Hormones in human metabolism and disease. Functional metabolism: regulation and adaptation. Weinheim: Wiley-VCH; 2004. p271.
9. Laakso M. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes. Prim Care 1999; 26: 829-39.
10. Schalkwijk C, Stehouwer C. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 2005; 109: 143-59.
11. Carlsson S, Midthjell K, Grill V. Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune diabetes in adults: an 11-year follow-up of incidence of diabetes in the Nord-Trondelag study. Diabetologia 2004; 47: 1953-6.
12. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298: 2654-64.
13. Eliasson B. Cigarete smoking and diabetes. Prog Cardiovasc Dis 2003; 45: 405-13.
14. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarete smoking. Lancet 1992; 339: 1128- 30.
15. Mitchell BD, Hawthorne VM, Vinik AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 1990; 13: 434-7.
16. Borggreve SE, De Vries R, Dullaart RP. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins. Eur J Clin Invest 2003; 33: 1051-69.
17. Despre JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.
18. Heine RJ, Dekker JM. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabeto-logia 2002; 45: 461-75.
19. Smith U, Axelsen M, Carvalho E, Eliasson B, Jansson PA, Wesslau C. Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 1999; 892: 119-26.
20. Madsbad S, McNair P, Christensen MS, Christiansen C, Faber OK, Binder C, et al. Infuence of smoking on insulin requirement and metbolic status in diabetes mellitus. Diabetes Care 1980; 3: 41-3.
21. Holloway AC, Lim GE, Petrik JJ, Foster WG, Morrison KM, Gerstein HC. Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes. Diabetologia 2005; 48: 2661-6.
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.
23. Axelsson T, Jansson PA, Smith U, Eliasson B. Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects. J Intern Med 2001; 249: 539-44.
24. Price TB, Krishnan-Sarin S, Rothman DL. Smoking impairs muscle recovery from exercise. Am J Physiol Endocrinol Metab 2003; 285: E116-22.
25. Conti-Fine BM, Navaneetham D, Lei S, Maus AD. Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 2000; 393: 279-94.
26. Ejiri K, Taniguchi H, Baba S. Participation of nicotinic receptor in hormone release from isolated rat islets of Langerhans. Diabetes Res Clin Pract 1989; 6: 53-9.
27. Nelson L, Gardner ME, Young MJ. Regulation of calciumdistribution in bovine sperm cells: cytochemical evidence for motility control mechanisms. Cell Motil 1982; 2: 225-42.
28. Yoshikawa H, Hellstrom-Lindahl E, Grill V. Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism 2005; 54: 247-54.
29. Stagner JI. Modulation of insulin secretion by pancreatic gang lionic nicotinic receptors. Diabetes 1986; 35: 849-54.
30. Somm E, Schwitzgebel VM, Vauthay DM, Camm EJ, Chen CY, Giacobino JP, et al. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 2008; 149: 6289-99.
31. Bruin JE, Gerstein HC, Morrison KM, Holloway AC. Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria. Toxicol Sci 2008; 103: 362-70.
32. Bruin JE, Petre MA, Raha S, Morrison KM, Gerstein HC, Holloway AC. Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction. PLoS ONE 2008; 3: e3371.
33. Bruin JE, Petre MA, Lehman MA, Raha S, Gerstein HC, Morrison KM, et al. Maternal nicotine exposure increases oxidative stress in the ofspring. Free Radic Biol Med 2008; 44: 1919-25.